Literature DB >> 15208970

Using liquid ventilation to improve lung function in patients with respiratory distress syndrome: a comprehensive review of the literature.

Jennifer B Hancock1, Susan Davidson, Cherry Guinn, Richard Zachary.   

Abstract

This article is a review of the research findings on the subject of liquid ventilation and how it has shown to improve lung function in patients with respiratory distress syndrome. An overview of the physiology behind the success of liquid ventilation, including current research outcomes, is presented. The literature documenting research data was obtained through an internet search of articles published from 1962 to 2002. Respiratory distress syndrome is a potential complication for any patient that has suffered damage to the lungs. It continues to carry a significantly high mortality rate, in spite of multiple conventional treatments currently in use. The latest clinical research has led to the development of a new treatment for the syndrome called liquid ventilation, whereby chemicals called perfluorocarbons are used as a medium to transport vital respiratory gases into and out of the lungs. Research on animal and human subjects has shown that liquid ventilation therapy can improve lung function in certain patients with severe pulmonary dysfunction when conventional treatments have failed.

Entities:  

Mesh:

Year:  2004        PMID: 15208970

Source DB:  PubMed          Journal:  AANA J        ISSN: 0094-6354


  4 in total

1.  Perfluoroalkyl substances are inversely associated with coronary heart disease in adults with diabetes.

Authors:  Kyoko Honda-Kohmo; Robert Hutcheson; Kim E Innes; Baqiyyah N Conway
Journal:  J Diabetes Complications       Date:  2019-02-20       Impact factor: 2.852

2.  Perfluoroalkyl substances and beta cell deficient diabetes.

Authors:  Baqiyyah Conway; Karen E Innes; Dustin Long
Journal:  J Diabetes Complications       Date:  2016-05-04       Impact factor: 2.852

3.  Perfluoroalkyl substances and kidney function in chronic kidney disease, anemia, and diabetes.

Authors:  Baqiyyah N Conway; Ashley N Badders; Tina Costacou; John M Arthur; Kim E Innes
Journal:  Diabetes Metab Syndr Obes       Date:  2018-11-15       Impact factor: 3.168

4.  Perfluoroalkyl substances and likelihood of stroke in persons with and without diabetes.

Authors:  Robert Hutcheson; Kim Innes; Baqiyyah Conway
Journal:  Diab Vasc Dis Res       Date:  2019-12-16       Impact factor: 3.291

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.